Predictors of invasive versus conservative treatment in elderly patients with acute coronary syndromes.

Original title: Predictors of Treatment in Acute Coronary Syndromes in the Elderly: Impact on Decision Making and Clinical Outcome After Interventional Versus Conservative Treatment. Reference: Harald Rittger et al. Catheterization and Cardiovascular Interventions 80:735–743 (2012).

This study, recently published in Cath Cardiovasc Interven, was performed to determine the factors that helped physicians decide to be conservative or invasive. Were analyzed retrospectively 1,001 consecutive patients over 75 years who were admitted for acute coronary syndromes with or without ST segment elevation (NSTACS or STACS).

The decision to perform catheterization and eventually an angioplasty or coronary artery bypass graft surgery was at the discretion of the treating physicians. Out of the patients analyzed, 754 (76%) were admitted for SCANST and 776 (77.5%) received an invasive strategy. An analysis was performed by logistic regression for multiple baseline characteristics and in that way potential intricacies were identified.

Predictors for a conservative strategy were:

  • Advanced age (the most powerful)
  • Killip III functional class
  • three-vessel injury
  • Prior stroke
  • Obesity
  • Previous renal failure
  • Type of acute coronary syndrome
  • Previous infarction
  • The presence of supraventricular arrhythmias.

Mortality from all causes in patients treated conservatively was 15.6% versus 3.5% of patients treated invasively, which is significantly in favor of an invasive strategy (p <0.001). The authors refer to an important limitation of the study: it is a retrospective analysis of a single center. However, the fact that patients are consecutive shows the reality of clinical practice beyond the trials and records for this age group.

Conclusion 

In this analysis, older age was the strongest predictor for a conservative approach. Other features that are associated with increased clinical risk also tipped the balance towards conservative treatment.

Editorial comment

The management of elderly patients with acute coronary syndromes has not been standardized, given the lack of evidence coming from randomized and multicenter studies. The recommendations of the guidelines have been made mostly by transferring the results of studies in much younger patients, which often leaves older patients in the hands of its natural evolution, mainly from fear of medical complications.

These complications are, of course, more frequent in elderly patients but in no way counterbalance the potential benefit of an invasive strategy over total mortality rates. The proportion of elderly patients entering our hospitals is increasing, (and still growing), so this dilemma will become more common in all coronary care units. 

Finally, we should bear in mind that we probably never have sufficient information from randomized and multicenter works designed specifically for elderly patients.

SOLACI.ORG

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...